Identification of natural compounds as SARS-CoV-2 inhibitors via molecular docking and molecular dynamic simulation
暂无分享,去创建一个
Peng Wu | Ziqing Luo | Yan-ni Lai | Tiantian Han | Gen Li | Xiaohong Liu | Lichun Ji
[1] Christopher J. L. Murray,et al. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. , 2022, JAMA.
[2] Q. Pan,et al. Hypericin blocks the function of HSV-1 alkaline nuclease and suppresses viral replication. , 2022, Journal of ethnopharmacology.
[3] A. Berghuis,et al. Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary Immunodeficiency , 2022, Frontiers in Microbiology.
[4] B. Balasubramanian,et al. Evaluation of Clove Phytochemicals as Potential Antiviral Drug Candidates Targeting SARS-CoV-2 Main Protease: Computational Docking, Molecular Dynamics Simulation, and Pharmacokinetic Profiling , 2022, Frontiers in Molecular Biosciences.
[5] J. Dushoff,et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa , 2022, Science.
[6] K. Balawender,et al. Does SARS-CoV-2 affect male urogenital system? , 2022, Current pharmaceutical biotechnology.
[7] S. Bhatt,et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study , 2022, The Lancet.
[8] Benjamin Bowe,et al. Long-term cardiovascular outcomes of COVID-19 , 2022, Nature Medicine.
[9] K. Almes,et al. Molecular detection of SARS-CoV-2 strains and differentiation of Delta variant strains. , 2021, Transboundary and emerging diseases.
[10] J. Zahradník,et al. The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance , 2021, Cell Reports.
[11] Marek J. Łos,et al. An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment , 2021, Drug Resistance Updates.
[12] Yeqing Sun,et al. Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination , 2021, Emerging microbes & infections.
[13] Xilong Deng,et al. Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China , 2021, EClinicalMedicine.
[14] Yudong Ren,et al. Hypericin Inhibit Alpha-Coronavirus Replication by Targeting 3CL Protease , 2021, Viruses.
[15] P. Romero,et al. The Emergence of Sars-CoV-2 Variant Lambda (C.37) in South America , 2021, medRxiv.
[16] Martin E. Garcia,et al. The SARS-CoV-2 spike protein is vulnerable to moderate electric fields , 2021, Nature Communications.
[17] R. Zarnegar,et al. Neurological manifestations as primary presentation of COVID‐19 in hospitalized patients , 2021, Acta neurologica Scandinavica.
[18] Kai Li,et al. ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Infection in COVID-19 Patients , 2021, Frontiers in Medicine.
[19] W. Cho,et al. An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies , 2020, Expert review of anti-infective therapy.
[20] Haiyong Peng,et al. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity , 2020, Nature Communications.
[21] J. Borgio,et al. Emerging of composition variations of SARS-CoV-2 spike protein and human ACE2 contribute to the level of infection: in silico approaches , 2020, Journal of biomolecular structure & dynamics.
[22] J. Davie,et al. Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus. , 2020, Genome.
[23] P. Rocchi,et al. Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting , 2020, Molecular Cell.
[24] A. Schmidtchen,et al. SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity , 2020, bioRxiv.
[25] Arumugam Priya,et al. Ethnomedicines of Indian origin for combating COVID-19 infection by hampering the viral replication: using structure-based drug discovery approach , 2020, Journal of biomolecular structure & dynamics.
[26] A. Singh,et al. Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies , 2020, Journal of biomolecular structure & dynamics.
[27] Linqi Zhang,et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor , 2020, Nature.
[28] Mohammad Madjid,et al. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. , 2020, JAMA cardiology.
[29] Li Xiaobo,et al. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) , 2020, Pharmacological Research.
[30] J. Patel,et al. COVID-19 and the liver: little cause for concern , 2020, The Lancet Gastroenterology & Hepatology.
[31] A. Walls,et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.
[32] Ai-Hua Zhang,et al. Traditional Chinese medicine for COVID-19 treatment , 2020, Pharmacological Research.
[33] Hyun Pyo Kim,et al. Therapeutic Potential of the Rhizomes of Anemarrhena asphodeloides and Timosaponin A-III in an Animal Model of Lipopolysaccharide-Induced Lung Inflammation , 2018, Biomolecules & therapeutics.
[34] S. Sung,et al. Anti‐inflammatory activity of mulberrofuran K isolated from the bark of Morus bombycis , 2018, International immunopharmacology.
[35] Sheng-Yong Yang,et al. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era , 2016, Briefings Bioinform..
[36] S. Piazza,et al. Strawberry tannins inhibit IL-8 secretion in a cell model of gastric inflammation. , 2016, Pharmacological research.
[37] J. Eloff,et al. Ochnaflavone and Ochnaflavone 7-O-Methyl Ether two Antibacterial Biflavonoids from Ochna pretoriensis (Ochnaceae) , 2012, Natural product communications.
[38] T. Huang,et al. Antihepatitis B Virus Constituents of Solanum Erianthum , 2012 .
[39] Y. Matsuura,et al. Tellimagrandin I, HCV invasion inhibitor from Rosae Rugosae Flos. , 2010, Bioorganic & medicinal chemistry letters.
[40] Yoshitaka Shimotai,et al. Anti-influenza virus principles from Muehlenbeckia hastulata , 2010, Journal of Natural Medicines.
[41] Ke Chen,et al. Investigation of Atomic Level Patterns in Protein—Small Ligand Interactions , 2009, PloS one.
[42] J. Thornton,et al. Stereochemical quality of protein structure coordinates , 1992, Proteins.
[43] Y. Cheng,et al. Anti-aids agents, 6. Salaspermic acid, an anti-HIV principle from Tripterygium wilfordii, and the structure-activity correlation with its related compounds. , 1992, Journal of natural products.
[44] D. Barnard,et al. Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus. , 1992, Antiviral research.